Genetic Analysis and Clinical Therapy in Head and Neck Cancers

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".

Deadline for manuscript submissions: 20 November 2024 | Viewed by 184

Special Issue Editor


E-Mail Website
Guest Editor
Department of Otolaryngology, University Hospital, “San Giovanni di Dio e Ruggi d’Aragona”, 84131 Salerno, Italy
Interests: tumor immunology; molecular pathogenesis; microcirculation; machine learning; salivary gland disorders; cancer diagnostics; cancer stem cells; regenerative medicine

Special Issue Information

Dear Colleagues,

This Special Issue, “Genetic Analysis and Clinical Therapy in Head and Neck Cancers”, aims to provide a comprehensive platform for researchers and clinicians to explore the intricate relationship between genetic factors and clinical therapeutic approaches in the context of head and neck cancers. As advances in genomic research continue to unravel the complexities of cancer biology, understanding the genetic underpinnings of head and neck cancers has become crucial for developing targeted and personalized treatment strategies. This Special Issue invites contributions that bridge the gap between genetic insights and clinical applications, fostering a deeper understanding of the molecular mechanisms driving these cancers and facilitating the translation of genetic knowledge into effective therapeutic interventions. Join us in advancing the frontiers of knowledge in head and neck cancer research, with a focus on integrating genetic analysis into clinical practice.

Dr. Alfonso Scarpa
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • head and neck cancers
  • genetic analysis
  • clinical therapy
  • personalized treatment
  • molecular mechanisms
  • cancer biology

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop